Effects of supplementation with L-carnitine in the heart of patients who will do coronary artery bypass graft

Not Applicable

Recruiting

• Conditions: C14.280.647; C14.280.434; Cardiovascular disease, myocardial ischemia, heart failure.

• Registration Number: RBR-57hj7n
• Lead Sponsor: niversidade Federal Fluminense

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-07-30
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Sixty adult patients; lucid; oriented; both genders; minimum age of 30 years and maximum age of 80 years; diagnostic systolic ischemic heart failure; requiring elective coronary artery bypass surgery; use of cardiopulmonary bypass (CPB); Ejection fraction of the left ventricle (LVEF) greater than or equal to 50% (Simpson method); left ventricular end-diastolic volume (LV Diastolic) greater than 150 mL / m²; end of the left ventricle systolic volume (LV Systolic) greater than 65 ml / m².

Exclusion Criteria

During treatment develop liver dysfunction; renal dysfunction; malabsorptive syndrome; stroke; sepsis; prolonged hemodynamic shock; Patients who discontinue supplementation.

Study & Design

• Study Type: Intervention
• Study Design: Not specified